New insights into the mechanisms of the ketogenic diet

Current Opinion in Neurology

Volumn 30, Issue 2, 2017, Pages 187-192

  Boison, Detlev ^a  

^a LEGACY RESEARCH   (United States)

Author keywords

epigenetics; epileptogenesis; ketones; metabolism; seizure suppression

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; AMPA RECEPTOR; ANTICONVULSIVE AGENT; DECANOIC ACID; KETONE BODY; LACTATE DEHYDROGENASE; MEDIUM CHAIN FATTY ACID; MEDIUM CHAIN TRIACYLGLYCEROL; NEUROTROPHIC FACTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; POLYUNSATURATED FATTY ACID; DECANOIC ACID DERIVATIVE;

AEROBIC METABOLISM; ANTIINFLAMMATORY ACTIVITY; AUTISM; BIOGENESIS; CHRONIC PAIN; DNA METHYLATION; ENZYME ACTIVITY; EPILEPSY; HUMAN; KETOACIDOSIS; KETOGENIC DIET; LIPID DIET; LOW CARBOHYDRATE DIET; MACROPHAGE; MITOCHONDRIAL BIOGENESIS; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PROTEIN RESTRICTION; REVIEW; SIGNAL TRANSDUCTION; SEIZURE;

ANTICONVULSANTS; DECANOIC ACIDS; DIET, KETOGENIC; EPILEPSY; HUMANS; SEIZURES;

EID: 85011697849     PISSN: 13507540     EISSN: 14736551     Source Type: Journal    
DOI: 10.1097/WCO.0000000000000432     Document Type: Review

References (50)

1. Freeman JM, Kossoff EH. Ketosis and the ketogenic diet, 2010: advances in treating epilepsy and other disorders. Adv Pediatr 2010; 57:315-329.
2. Stafstrom CE, Rho JM. The ketogenic diet as a treatment paradigm for diverse neurological disorders. Front Pharmacol 2012; 3:59.
3. Taub KS, Kessler SK, Bergqvist AG. Risk of seizure recurrence after achieving initial seizure freedom on the ketogenic diet. Epilepsia 2014; 55:579-583.
4. Rho JM. How does the ketogenic diet induce anti-seizure effects? Neurosci Lett 2015; 637:4-10.
5. Masino SA, Rho JM. Mechanisms of ketogenic diet action. In: Noebels JL, Avoli M, Rogawski MA, et al., editors. Jaspers basic mechanisms of the epilepsies, 4th ed Bethesda (MD), USA: National Center for Biotechnology Information (US); 2012.
6. Lutas A, Yellen G. The ketogenic diet: metabolic influences on brain excitability and epilepsy. Trends Neurosci 2013; 36:32-40.
7. Lambrechts DA, Brandt-Wouters E, Verschuure P, et al. A prospective study on changes in blood levels of cholecystokinin-8 and leptin in patients with refractory epilepsy treated with the ketogenic diet. Epilepsy Res 2016; 127:87-92.
8. Sariego-Jamardo A, Garcia-Cazorla A, Artuch R, et al. Efficacy of the ketogenic diet for the treatment of refractory childhood epilepsy: cerebrospinal fluid neurotransmitters and amino acid levels. Pediatr Neurol 2015; 53: 422-426.
9. Schoeler NE, Leu C, White J, et al. Variants in KCNJ11 and BAD do not predict response to ketogenic dietary therapies for epilepsy. Epilepsy Res 2015; 118:22-28.
10. Youm YH, Nguyen KY, Grant RW, et al. The ketone metabolite b-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nat Med 2015; 21:263-269.
11. Rahman M, Muhammad S, Khan MA, et al. The b-hydroxybutyrate receptor HCA2 activates a neuroprotective subset of macrophages. Nat Commun 2014; 5:3944.
12. Valente-Silva P, Lemos C, Kofalvi A, et al. Ketone bodies effectively compete with glucose for neuronal acetyl-CoA generation in rat hippocampal slices. NMR Biomed 2015; 28:1111-1116.
13. Zhang Y, Zhang S, Marin-Valencia I, Puchowicz MA. Decreased carbon shunting from glucose toward oxidative metabolism in diet-induced ketotic rat brain. J Neurochem 2015; 132:301-312.
14. Spilioti M, Pavlou E, Gogou M, et al. Valproate effect on ketosis in children under ketogenic diet. Eur J Paediatr Neurol 2016; 20:555-559.
15. Hrynevich SV, Waseem TV, Hebert A, et al. b-Hydroxybutyrate supports synaptic vesicle cycling but reduces endocytosis and exocytosis in rat brain synaptosomes. Neurochem Int 2016; 93:73-81.
16. Viggiano A, Pilla R, Arnold P, et al. Anticonvulsant properties of an oral ketone ester in a pentylenetetrazole-model of seizure. Brain Res 2015; 1618:50-54.
17. Ciarlone SL, Grieco JC, D'Agostino DP, Weeber EJ. Ketone ester supplementation attenuates seizure activity, and improves behavior and hippocampal synaptic plasticity in an Angelman syndrome mouse model. Neurobiol Dis 2016; 96:38-46.
18. Chang P, Terbach N, Plant N, et al. Seizure control by ketogenic dietassociated medium chain fatty acids. Neuropharmacology 2013; 69:105-114.
19. Marin-Valencia I, Good LB, Ma Q, et al. Heptanoate as a neural fuel: energetic and neurotransmitter precursors in normal and glucose transporter I-deficient (G1D) brain. J Cereb Blood Flow Metab 2013; 33:175-182.
20. Pascual JM, Liu P, Mao D, et al. Triheptanoin for glucose transporter type I deficiency (G1D): modulation of human ictogenesis, cerebral metabolic rate, and cognitive indices by a food supplement. JAMA Neurol 2014; 71:1255-1265.
21. Chang P, Zuckermann AM, Williams S, et al. Seizure control by derivatives of medium chain fatty acids associated with the ketogenic diet show novel branching-point structure for enhanced potency. J Pharmacol Exp Ther 2015; 352:43-52.
22. Tan KN, Carrasco-Pozo C, McDonald TS, et al. Tridecanoin is anticonvulsant, antioxidant, and improves mitochondrial function. J Cereb Blood Flow Metab 2016. [Epub ahead of print]
23. Kanabus M, Fassone E, Hughes SD, et al. The pleiotropic effects of decanoic acid treatment on mitochondrial function in fibroblasts from patients with complex I deficient Leigh syndrome. J Inherit Metab Dis 2016; 39:415-426.
24. Hughes SD, Kanabus M, Anderson G, et al. The ketogenic diet component decanoic acid increases mitochondrial citrate synthase and complex I activity in neuronal cells. J Neurochem 2014; 129:426-433.
25. Thevenet J, De Marchi U, Domingo JS, et al. Medium-chain fatty acids inhibit mitochondrial metabolism in astrocytes promoting astrocyte-neuron lactate and ketone body shuttle systems. FASEB J 2016; 30:1913-1926.
26. Maciejak P, Szyndler J, Turzynska D, et al. Is the interaction between fatty acids and tryptophan responsible for the efficacy of a ketogenic diet in epilepsy? The new hypothesis of action. Neuroscience 2016; 313:130-148.
27. Chang P, Augustin K, Boddum K, et al. Seizure control by decanoic acid through direct AMPA receptor inhibition. Brain 2016; 139:431-443.
28. Yazdi S, Stein M, Elinder F, et al. The molecular basis of polyunsaturated fatty acid interactions with the shaker voltage-gated potassium channel. PLoS Comput Biol 2016; 12:e1004704.
29. Dustin SM, Stafstrom CE. Ketogenic diet, but not polyunsaturated fatty acid diet, reduces spontaneous seizures in juvenile rats with kainic acid-induced epilepsy. J Epilepsy Res 2016; 6:1-7.
30. Dupuis N, Curatolo N, Benoist JF, Auvin S. Ketogenic diet exhibits antiinflammatory properties. Epilepsia 2015; 56:e95-e98.
31. Shao M, Shan B, Liu Y, et al. Hepatic IRE1a regulates fasting-induced metabolic adaptive programs through the XBP1s-PPARalpha axis signalling. Nat Commun 2014; 5:3528.
32. Simeone TA, Samson KK, Matthews SA, Simeone KA. In vivo ketogenic diet treatment attenuates pathologic sharp waves and high frequency oscillations in in vitro hippocampal slices from epileptic Kv 1.1a knockout mice. Epilepsia 2014; 55:e44-e49.
33. Simeone TA, Matthews SA, Samson KK, Simeone KA. Regulation of brain PPARgamma2 contributes to ketogenic diet anti-seizure efficacy. Exp Neurol 2017; 287:54-64.
34. Gimenez-Cassina A, Martinez-Francois JR, Fisher JK, et al. BAD-dependent regulation of fuel metabolism and K(ATP) channel activity confers resistance to epileptic seizures. Neuron 2012; 74:719-730.
35. Kim DY, Abdelwahab MG, Lee SH, et al. Ketones prevent oxidative impairment of hippocampal synaptic integrity through KATP channels. PLoS One 2015; 10:e0119316.
36. Lutas A, Birnbaumer L, YellenG.Metabolism regulates the spontaneous firing of substantia nigra pars reticulata neurons via KATP and nonselective cation channels. J Neurosci 2014; 34:16336-16347.
37. Genzer Y, Dadon M, Burg C, et al. Effect of dietary fat and the circadian clock on the expression of brain-derived neurotrophic factor (BDNF). Mol Cell Endocrinol 2016; 430:49-55.
38. Vizuete AF, de Souza DF, Guerra MC, et al. Brain changes in BDNF and S100B induced by ketogenic diets in Wistar rats. Life Sci 2013; 92:923-928.
39. Dahlin M, Martin DA, Hedlund Z, et al. The ketogenic diet compensates for AGC1 deficiency and improves myelination. Epilepsia 2015; 56:e176-e181.
40. Kumar MG, Rowley S, Fulton R, et al. Altered glycolysis and mitochondrial respiration in a zebrafish model of Dravet syndrome. eNeuro 2016; 3. (2):ENEURO.0008-16.2016.
41. Kim DY, Simeone KA, Simeone TA, et al. Ketone bodies mediate antiseizure effects through mitochondrial permeability transition. Ann Neurol 2015; 78:77-87.
42. Jin Z, Berthiaume JM, Li Q, et al. Catabolism of (2E)-4-hydroxy-2-nonenal via v-and v-1-oxidation stimulated by ketogenic diet. J Biol Chem 2014; 289:32327-32338.
43. Laeger T, Henagan TM, Albarado DC, et al. FGF21 is an endocrine signal of protein restriction. J Clin Invest 2014; 124:3913-3922.
44. Sada N, Lee S, Katsu T, et al. Epilepsy treatment. Targeting LDH enzymes with a stiripentol analog to treat epilepsy. Science 2015; 347:1362-1367.
45. Simeone KA, Matthews SA, Rho JM, Simeone TA. Ketogenic diet treatment increases longevity in Kcna1-null mice, a model of sudden unexpected death in epilepsy. Epilepsia 2016; 57:e178-e182.
46. Kobow K, Kaspi A, Harikrishnan KN, et al. Deep sequencing reveals increased DNA methylation in chronic rat epilepsy. Acta Neuropathol 2013; 126:741-756.
47. Lusardi TA, Akula KK, Coffman SQ, et al. Ketogenic diet prevents epileptogenesis and disease progression in adult mice and rats. Neuropharmacology 2015; 99:500-509.
48. Masino SA, Li T, Theofilas P, et al. A ketogenic diet suppresses seizures in mice through adenosine A1 receptors. J Clin Inv 2011; 121:2679-2683.
49. Williams-Karnesky RL, Sandau US, Lusardi TA, et al. Epigenetic changes induced by adenosine augmentation therapy prevent epileptogenesis. J Clin Inv 2013; 123:3552-3563.
50. Newell C, Bomhof MR, Reimer RA, et al. Ketogenic diet modifies the gut microbiota in a murine model of autism spectrum disorder. Mol Autism 2016; 7:37.